212 related articles for article (PubMed ID: 10807498)
1. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
Amon U; Gibbs BF; Buss G; Nitschke M
Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
Mita H; Shida T
Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
5. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
6. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
Mochizuki Y; Furuta A; Furuya A; Kanai K; Asano K; Suzaki H
In Vivo; 2008; 22(1):13-20. PubMed ID: 18396776
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
8. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
9. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
10. A novel antiallergic drug epinastine inhibits IL-8 release from human eosinophils.
Kohyama T; Takizawa H; Akiyama N; Sato M; Kawasaki S; Ito K
Biochem Biophys Res Commun; 1997 Jan; 230(1):125-8. PubMed ID: 9020026
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
[TBL] [Abstract][Full Text] [Related]
12. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Misawa M; Kanai Y
Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
Fügner A; Meissner C
Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
[TBL] [Abstract][Full Text] [Related]
14. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Galatowicz G; Ajayi Y; Stern ME; Calder VL
Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
[TBL] [Abstract][Full Text] [Related]
15. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils.
Ohmori K; Manabe H; Akuta-Ohnuma K
Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030
[TBL] [Abstract][Full Text] [Related]
19. Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis.
Matsukura M; Yajima A; Yamazaki F; Yudate T; Yamada H; Tezuka T
Skin Pharmacol Appl Skin Physiol; 2003; 16(6):405-10. PubMed ID: 14528065
[TBL] [Abstract][Full Text] [Related]
20. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]